. Apmnews, Les françaises prennent 9 médicaments en médiane pendant la grossesse, 2017.

D. M. Haas, D. J. Marsh, D. T. Dang, C. B. Parker, D. A. Wing et al., Prescription and Other Medication Use in Pregnancy, Obstet Gynecol. 6 avr, 2018.

A. Lupatelli, O. Spigset, and M. J. Twigg, Medication use in pregancy: a cross-sectional, mutinational, web-based study, BMJ open, 2014.

M. M. Werler, A. A. Mitchell, S. Hernandez-diaz, and M. A. Honein, Use of OTC medications during pregnancy, Journal Obstetrics Gynecology, 2005.

, IPSOS Santé pour la Caisse Nationale de, l'Assurance Maladie. Le rapport des Français et des Européens à l'ordonnance et aux médicaments, févr, vol.6, 2005.

K. Kenan, K. Mack, and L. Paulozzi, Trends in prescriptions for oxycodone and other commonly used opioids in the United States, Open Med, vol.6, issue.2, pp.41-47, 2000.

L. Shamseer, D. Moher, M. Clarke, D. Ghersi, A. Liberati et al., Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation, BMJ, vol.02, p.7647, 2015.

, Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training

A. Fowden, A. Forhead, P. Coan, and G. Burton, The placenta and intra-uterine programming, Journal neuroendocrinol, 2008.

M. Syme, J. Paxton, and J. Keelan, Drug tranfer and metabolism by the human placenta, Clinical Pharmacokinetic, 2004.

M. Hill and F. Abramson, The significance of plasma protein binding on the foetal/maternal distribution of drugs at steady-state, Clin Pharmacokinet, 1988.

H. R. Price and A. C. Collier, Analgesics in Pregnancy: An Update on Use, Safety and Pharmacokinetic Changes in Drug Disposition, Curr Pharm Des. 25 août, 2017.

R. Loebstein, A. Lalkin, and G. Koren, Pharmacokinetic changes during pregnancy and their clinical relevance, Clin Pharmacokinet. nov, vol.33, issue.5, pp.328-371, 1997.

J. Hakkola, H. Raunio, R. Purkunen, O. Pelkonen, S. Saarikoski et al., Detection of cytochrome P450 gen expression in human placenta in first trimester of pregancy, Biochem Pharmacol, 1996.

F. Burdan, A. Chalas, and J. Szumilo, Cyclooxygenase and postanoids-biological implication, Postepy Hig Med Dosw (online), 2006.

G. Graham and K. Scott, Mechanism of action of paracetamol, Am J Ther, 2005.

I. Zagon, M. Verderame, and P. Mclaughlin, The biology of the opioid growth factor receptor (OGFr), 2002.

R. Koniman, Y. H. Chan, T. N. Tan, V. Bever, and H. P. , A matched patient-sibling study on the usage of paracetamol and the subsequent development of allergy and asthma, Pediatr Allergy Immunol. mars, vol.18, issue.2, pp.128-162, 2007.

L. Garcia-marcos, M. Sanchez-solis, V. Perez-fernandez, M. D. Pastor-vivero, P. Mondejarlopez et al., Is the effect of prenatal paracetamol exposure on wheezing in preschool children modified by asthma in the mother?, Int Arch Allergy Immunol, vol.149, issue.1, pp.33-40, 2009.

J. Headley, K. Northstone, H. Simmons, and J. Golding, ALSPAC Study Team. Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children, Eur J Clin Pharmacol. juill, vol.60, issue.5, pp.355-61, 2004.

S. O. Shaheen, R. B. Newson, A. J. Henderson, J. E. Headley, F. D. Stratton et al., Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood, Clin Exp Allergy. janv, vol.35, issue.1, pp.18-25, 2005.

A. E. Varner, W. W. Busse, and R. F. Lemanske, Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma, Ann Allergy Asthma Immunol. oct, vol.81, issue.4, pp.347-51, 1998.

R. B. Newson, S. O. Shaheen, S. Chinn, and P. G. Burney, Paracetamol sales and atopic disease in children and adults: an ecological analysis, Eur Respir J. nov, vol.16, issue.5, pp.817-840, 2000.

A. R. Scialli, R. Ang, J. Breitmeyer, and M. A. Royal, Childhood asthma and use during pregnancy of acetaminophen. A critical review, Reprod Toxicol. déc, vol.30, issue.4, pp.508-527, 2010.

S. O. Shaheen, R. B. Newson, A. Sherriff, A. J. Henderson, J. E. Heron et al., Paracetamol use in pregnancy and wheezing in early childhood, Thorax. nov, vol.57, issue.11, pp.958-63, 2002.

C. Rebordosa, M. Kogevinas, H. T. Sørensen, and J. Olsen, Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: a birth cohort study, Int J Epidemiol. juin, vol.37, issue.3, pp.583-90, 2008.

E. Bakkeheim, P. Mowinckel, K. H. Carlsen, G. Håland, and K. Carlsen, Paracetamol in early infancy: the risk of childhood allergy and asthma, Acta Paediatr. janv, vol.100, issue.1, pp.90-96, 2011.

E. M. Kang, L. S. Lundsberg, J. L. Illuzzi, and M. B. Bracken, Prenatal exposure to acetaminophen and asthma in children, Obstet Gynecol. déc, vol.114, issue.6, pp.1295-306, 2009.

S. Eyers, M. Weatherall, S. Jefferies, and R. Beasley, Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis, Clin Exp Allergy. avr, vol.41, issue.4, pp.482-491, 2011.

H. Thengilsdottir, E. Goksor, and B. Alm, Paracetamol in pregancy seems to increase the risk of multiple-trigger wheeze but not overall wheezing disorder in preschool age, Allergy, vol.65

M. Cheelo, C. J. Lodge, S. C. Dharmage, J. A. Simpson, M. Matheson et al., Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis, Arch Dis Child. janv, vol.100, issue.1, pp.81-90, 2015.

A. Andersen, D. K. Farkas, F. Mehnert, V. Ehrenstein, and R. Erichsen, Use of prescription paracetamol during pregnancy and risk of asthma in children: a population-based Danish cohort study, Clin Epidemiol, vol.4, pp.33-40, 2012.

B. Källén, O. Finnström, and K. Nygren, Otterblad Olausson P. Maternal drug use during pregnancy and asthma risk among children, Pediatr Allergy Immunol. févr, vol.24, issue.1, pp.28-32, 2013.

G. Fan, B. Wang, C. Liu, and D. Li, Prenatal paracetamol use and asthma in childhood: A systematic review and meta-analysis, Allergol Immunopathol, vol.45, issue.6, pp.528-561, 2017.

X. Liu, Z. Liew, J. Olsen, L. H. Pedersen, B. H. Bech et al., Association of prenatal exposure to acetaminophen and coffee with childhood asthma, Pharmacoepidemiol Drug Saf. févr, vol.25, issue.2, pp.188-95, 2016.

M. C. Magnus, Ø. Karlstad, S. E. Håberg, P. Nafstad, D. Smith et al., Prenatal and infant paracetamol exposure and development of asthma: the Norwegian Mother and Child Cohort Study, Int J Epidemiol, vol.45, issue.2, pp.512-534, 2016.

H. Viberg, P. Eriksson, T. Gordh, and A. Fredriksson, Paracetamol (acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult male mice, Toxicol Sci. mars, vol.138, issue.1, pp.139-186, 2014.

C. A. Frye, E. Bo, G. Calamandrei, L. Calzà, F. Dessì-fulgheri et al., Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems, J Neuroendocrinol. janv, vol.24, issue.1, pp.144-59, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00750171

T. Colborn, Neurodevelopment and endocrine disruption, Environ Health Perspect. juin, vol.112, issue.9, pp.944-953, 2004.

K. L. Howdeshell, A model of the development of the brain as a construct of the thyroid system, Environ Health Perspect. juin, vol.110, issue.3, pp.337-385, 2002.

S. L. Nuttall, J. N. Khan, G. H. Thorpe, N. Langford, and M. J. Kendall, The impact of therapeutic doses of paracetamol on serum total antioxidant capacity, J Clin Pharm Ther. août, vol.28, issue.4, pp.289-94, 2003.

D. E. Rollins, V. Bahr, C. Glaumann, H. Moldéus, P. Rane et al., Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells, Science. 28 sept, vol.205, issue.4413, pp.1414-1420, 1979.

R. Vlenterie, M. E. Wood, R. E. Brandlistuen, N. Roeleveld, M. M. Van-gelder et al., Neurodevelopmental problems at 18 months among children exposed to paracetamol in utero -A propensity score matched cohort study, Pharmacoepidemiol Drug Saf, vol.25, pp.296-303, 2016.

R. E. Brandlistuen, E. Ystrom, I. Nulman, G. Koren, and H. Nordeng, Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study, Int J Epidemiol. 1 déc, vol.42, issue.6, pp.1702-1715, 2013.

J. Olsen and Z. Liew, Fetal programming of mental health by acetaminophen? Response to the SMFM statement: prenatal acetaminophen use and ADHD, Expert Opin Drug Saf. déc, vol.16, issue.12, pp.1395-1403, 2017.

, Electronic address: pubs@smfm.org. Prenatal acetaminophen use and outcomes in children, Society for Maternal-Fetal Medicine (SMFM) Publications Committee, vol.216, pp.14-19, 2017.

Z. Liew, B. Ritz, C. Rebordosa, P. Lee, and J. Olsen, Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders, JAMA Pediatr. avr, vol.168, issue.4, pp.313-333, 2014.

Z. Liew, B. Ritz, J. Virk, and J. Olsen, Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: A Danish national birth cohort study, Autism Res. sept, vol.9, issue.9, pp.951-959, 2016.

E. Stergiakouli, A. Thapar, D. Smith, and G. , Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding, JAMA Pediatr, vol.170, issue.10, pp.964-70, 2016.

E. Ystrom, K. Gustavson, R. E. Brandlistuen, G. P. Knudsen, P. Magnus et al., Prenatal Exposure to Acetaminophen and Risk of ADHD. Pediatrics, vol.140, p.20163840, 2017.
DOI : 10.1542/peds.2016-3840

URL : https://pediatrics.aappublications.org/content/pediatrics/140/5/e20163840.full.pdf

R. Masarwa, H. Levine, E. Gorelik, S. Reif, A. Perlman et al., Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies, Am J Epidemiol. 24 avr, 2018.

M. Jensen, C. Rebordosa, and A. Thulstrup, Maternal use of acetaminophen, ibuprofen and acetylsalicylic acid during pregnancy and risk of cryptorchidism, Epidemiology, 2010.

P. Hurtado-gonzalez and R. T. Mitchell, Analgesic use in pregnancy and male reproductive development, Curr Opin Endocrinol Diabetes Obes, vol.24, issue.3, pp.225-257, 2017.
DOI : 10.1097/med.0000000000000338

URL : https://www.pure.ed.ac.uk/ws/files/32824285/MED240309.pdf

A. R. Scialli, R. Ang, J. Breitmeyer, and M. A. Royal, A review of the literature on the effects of acetaminophen on pregnancy outcome, Reprod Toxicol. déc, vol.30, issue.4, pp.495-507, 2010.

C. Rebordosa, M. Kogevinas, E. Horvath-puho, B. Norgard, M. Morales et al., Acetaminophen use during pregnancy : effects on risk for congenital abnormalities, Am J Obstet Gynecol, 2008.
DOI : 10.1097/01.aoa.0000326392.65734.4f

N. Rani, S. S. Gomathi, S. Sambathkumar, and R. , Monster phase of acetaminophen use in pregnancy: Current vision of an old drug, Int J Pharmcy Pharm Sci, vol.8, issue.11, pp.25-32, 2016.

M. M. Nelson and J. O. Forfar, Associations between drugs administered during pregnancy and congenital abnormalities of the fetus, Br Med J. 6 mars, vol.1, issue.5748, pp.523-530, 1971.

H. Jick, L. B. Holmes, J. R. Hunter, S. Madsen, and A. Stergachis, First-trimester drug use and congenital disorders, JAMA. 24 juill, vol.246, issue.4, pp.343-349, 1981.
DOI : 10.1097/00004714-198202000-00038

P. Aselton, H. Jick, A. Milunsky, J. R. Hunter, and A. Stergachis, First-trimester drug use and congenital disorders, Obstet Gynecol. avr, vol.65, issue.4, pp.451-456, 1985.

A. M. Thulstrup, H. T. Sørensen, G. L. Nielsen, L. Andersen, D. Barrett et al., Fetal growth and adverse birth outcomes in women receiving prescriptions for acetaminophen during pregnancy. EuroMap Study Group, Am J Perinatol, vol.16, issue.7, pp.321-327, 1999.
DOI : 10.1055/s-2007-993879

M. L. Feldkamp, R. E. Meyer, S. Krikov, and L. D. Botto, Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study, Obstet Gynecol. janv, vol.115, issue.1, pp.109-124, 2010.

L. Bremer, J. Goletzke, C. Wiessner, M. Pagenkemper, C. Gehbauer et al., Paracetamol Medication During Pregnancy: Insights on Intake Frequencies, Dosages and Effects on Hematopoietic Stem Cell Populations in Cord Blood From a Longitudinal Prospective Pregnancy Cohort, 2017.

G. Tiegs and G. Tiegs@uke, Martinistrasse, vol.52

M. E. Østensen and J. F. Skomsvoll, Anti-inflammatory pharmacotherapy during pregnancy, Expert Opin Pharmacother. mars, vol.5, issue.3, pp.571-80, 2004.

R. Antonucci, M. Zaffanello, E. Puxeddu, A. Porcella, L. Cuzzolin et al., Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn, Curr Drug Metab. 1 mai, vol.13, issue.4, pp.474-90, 2012.

I. B. Van-den-veyver, K. J. Moise, C. N. Ou, and R. J. Carpenter, The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus, Obstet Gynecol. oct, vol.82, issue.4, pp.500-503, 1993.

A. Tarcan, B. Gürakan, S. Yildirim, S. Ozkiraz, and B. Bilezikçi, Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure, J Perinat Med, vol.32, issue.1, pp.98-107, 2004.

G. Koren, A. Florescu, A. M. Costei, R. Boskovic, and M. E. Moretti, Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis, Ann Pharmacother. mai, vol.40, issue.5, pp.824-833, 2006.

A. T. Shastri, D. Abdulkarim, and P. Clarke, Maternal diclofenac medication in pregnancy causing in utero closure of the fetal ductus arteriosus and hydrops, Pediatr Cardiol, vol.34, issue.8, pp.1925-1932, 2013.

M. Gewillig, S. C. Brown, L. De-catte, A. Debeer, B. Eyskens et al., Premature foetal closure of the arterial duct: clinical presentations and outcome, Eur Heart J. juin, vol.30, issue.12, pp.1530-1536, 2009.

M. Bloor and M. Paech, Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation, Anesth Analg. mai, vol.116, issue.5, pp.1063-75, 2013.

L. J. Van-marter, A. Leviton, E. N. Allred, M. Pagano, K. F. Sullivan et al., Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy, Pediatrics. mai, vol.97, issue.5, pp.658-63, 1996.

L. J. Van-marter, S. Hernandez-diaz, M. M. Werler, C. Louik, and A. A. Mitchell, Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn, Pediatrics. janv, vol.131, issue.1, pp.79-87, 2013.

H. R. Nakhai-pour and A. Bérard, Major malformations after first trimester exposure to aspirin and NSAIDs, Expert Rev Clin Pharmacol. sept, vol.1, issue.5, pp.605-621, 2008.

A. Ericson and B. A. Källén, Nonsteroidal anti-inflammatory drugs in early pregnancy, Reprod Toxicol. août, vol.15, issue.4, pp.371-376, 2001.

B. Ofori, D. Oraichi, L. Blais, E. Rey, and A. Bérard, Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study, Birth Defects Res B Dev Reprod Toxicol. août, vol.77, issue.4, pp.268-79, 2006.

L. Y. Chan, P. Y. Chiu, S. S. Siu, and T. K. Lau, A study of diclofenac-induced teratogenicity during organogenesis using a whole rat embryo culture model. Hum Reprod, vol.16, pp.2390-2393, 2001.

L. Cuzzolin, V. Fanos, B. Pinna, M. Di-marzio, M. Perin et al., Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions, Pediatr Nephrol. juill, vol.21, issue.7, pp.931-939, 2006.

M. Cassina, D. Santis, M. Cesari, E. Van-eijkeren, M. Berkovitch et al., First trimester diclofenac exposure and pregnancy outcome, Reprod Toxicol, vol.30, issue.3, pp.401-405, 2010.
DOI : 10.1016/j.reprotox.2010.04.010

A. Coomarasamy, H. Honest, S. Papaioannou, H. Gee, and K. S. Khan, Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review, Obstet Gynecol. juin, vol.101, issue.6, pp.1319-1351, 2003.

O. Ozturk, M. Greaves, and A. Templeton, Aspirin dilemma. Remodelling the hypothesis from a fertility perspective, Hum Reprod. mai, vol.17, issue.5, pp.1146-1154, 2002.

D. Swiet, M. Fryers, and G. , The use of aspirin in pregnancy, J OBSTET GYNAECOL, vol.10, issue.6, pp.467-82, 1990.

I. D. Richards, Congenital malformations and environmental influences in pregnancy, Br J Prev Soc Med. nov, vol.23, issue.4, pp.218-243, 1969.
DOI : 10.1136/jech.23.4.218

URL : http://jech.bmj.com/content/23/4/218.full.pdf

I. Saxén, The association between maternal influenza, drug consumption and oral clefts, Acta Odontol Scand, vol.33, issue.5, pp.259-67, 1975.

S. Zierler, Maternal drugs and congenital heart disease, Obstet Gynecol. févr, vol.65, issue.2, pp.155-65, 1985.

E. Kozer, S. Nikfar, A. Costei, R. Boskovic, I. Nulman et al., Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis, Am J Obstet Gynecol. déc, vol.187, issue.6, pp.1623-1653, 2002.

M. M. Werler, J. E. Sheehan, and A. A. Mitchell, Maternal medication use and risks of gastroschisis and small intestinal atresia, Am J Epidemiol. 1 janv, vol.155, issue.1, pp.26-31, 2002.
DOI : 10.1093/aje/155.1.26

URL : https://academic.oup.com/aje/article-pdf/155/1/26/311056/26.pdf

E. Kozer, A. M. Costei, R. Boskovic, I. Nulman, S. Nikfar et al., Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis, Birth Defects Res B Dev Reprod Toxicol. févr, vol.68, issue.1, pp.70-84, 2003.

M. Bloor, M. J. Paech, and R. Kaye, Tramadol in pregnancy and lactation, Int J Obstet Anesth. avr, vol.21, issue.2, pp.163-170, 2012.

M. M. Yazdy, R. J. Desai, and S. B. Brogly, Prescription Opioids in Pregnancy and Birth Outcomes: A Review of the Literature, J Pediatr Genet. 1 avr, vol.4, issue.2, pp.56-70, 2015.

B. Källen, N. Borg, and M. Reis, The use of central nervous system active drugs during pregnancy, Pharmaceuticals, 2013.

M. V. Smith, D. Costello, and K. A. Yonkers, Clinical correlates of prescription opioid analgesic use in pregnancy, Matern Child Health J. mars, vol.19, issue.3, pp.548-56, 2015.

C. S. Broussard, S. A. Rasmussen, J. Reefhuis, J. M. Friedman, M. W. Jann et al., Maternal treatment with opioid analgesics and risk for birth defects, Am J Obstet Gynecol. avr, vol.204, issue.4, pp.314-315, 2011.

M. M. Yazdy, A. A. Mitchell, S. C. Tinker, S. E. Parker, and M. M. Werler, Periconceptional use of opioids and the risk of neural tube defects, Obstet Gynecol, vol.122, issue.4, pp.838-882, 2013.

M. B. Bracken and T. R. Holford, Exposure to prescribed drugs in pregnancy and association with congenital malformations, Obstet Gynecol. sept, vol.58, issue.3, pp.336-380, 1981.

B. Källen, Drugs during pregnancy, Nova Biomedical Book, 2009.

S. W. Patrick, J. Dudley, P. R. Martin, F. E. Harrell, M. D. Warren et al., Prescription opioid epidemic and infant outcomes, Pediatrics. mai, vol.135, issue.5, pp.842-50, 2015.

R. M. Hoover, V. Hayes, and J. Erramouspe, Association Between Prenatal Acetaminophen Exposure and Future Risk of Attention Deficit/Hyperactivity Disorder in Children, Ann Pharmacother. déc, vol.49, issue.12, pp.1357-61, 2015.

L. De-fays, K. Van-malderen, D. Smet, K. Sawchik, J. Verlinden et al., Use of paracetamol during pregnancy and child neurological development, Dev Med Child Neurol. août, vol.57, issue.8, pp.718-742, 2015.

A. Aminoshariae and A. Khan, Acetaminophen: old drug, new issues, J Endod. mai, vol.41, issue.5, pp.588-93, 2015.

F. Coluzzi, H. Valensise, M. Sacco, and M. Allegri, Chronic pain management in pregnancy and lactation, Minerva Anestesiol. févr, vol.80, issue.2, pp.211-235, 2014.

M. C. Brennan and W. F. Rayburn, Counseling about risks of congenital anomalies from prescription opioids, Birth Defects Res Part A Clin Mol Teratol. août, vol.94, issue.8, pp.620-625, 2012.

A. Schoenfeld, Y. Bar, P. Merlob, and Y. Ovadia, NSAIDs: maternal and fetal considerations, Am J Reprod Immunol. déc, vol.28, issue.3-4, pp.141-148, 1992.

I. Annexes-annexe, Opioid Partial Agonists"[TW] OR "opioid analgesics"[TW] OR "anti-inflammatory agents, non-steroidal"[MH] OR "antiinflammatory agents, non-steroidal"[TW] OR "nonsteroidal antiinflammatory agents"[TW] OR "Non-Steroidal Anti-Rheumatic agents

, Adverse reaction to paracetamol"[TW] OR "Paracetamol measurement

, /exp OR 'paracetamol poisoning'/exp OR 'analgesic agent'/exp) AND ('pregnancy'/exp OR 'pregnancy complication'/exp OR 'pregnant woman'/exp OR 'maternal exposure'/exp OR 'intrauterine growth retardation'/exp OR 'microsomia'/exp OR 'fetomaternal transfusion'/exp OR 'hydramnios'/exp) NOT 'breeding'/exp AND, EMBASE

. Cochrane-#1, OR "aspirin like agents" OR "analgesics, Anti-Inflammatory" OR "nsaids" OR "analgesics, anti inflammatory" OR "Non-Steroidal antirheumatic agents" OR "acetaminophen" OR "Paracetamol poisoning" OR, analgesics, opioid" OR "opioids" OR "opioid analgesics" OR "anti-inflammatory agents, non-steroidal

, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je donnerai mes soins à l'indigent et à quiconque me les demandera. Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

, En présence des Maîtres de cette FACULTE et de mes chers CONDISCIPLES, je promets et je jure d'être fidèle aux lois de l'Honneur et de la Probité dans l

, Admis dans l'intérieur des maisons, mes yeux ne verront pas ce qui s'y passe, ma langue taira les secrets qui me seront confiés et mon état ne servira pas à corrompre les moeurs ni à favoriser le crime

, Respectueux et reconnaissant envers mes MAÎTRES, je rendrai à leurs enfants l'instruction que j'ai reçue de leurs pères

, Que les HOMMES m'accordent leur estime si je suis fidèle à mes promesses. Que je sois couvert d'OPPROBRE et méprisé de mes confrères si j'y manque

. How and . Koy, Laëtitia Consommation d'antalgiques pendant la grossesse et ses conséquences: une revue de la littérature